Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Grant or award EVP, General Counsel & Sec acquired 67,875 shares (grant or award)
  2. 4 Grant or award EVP, Commercial acquired 70,715 shares (grant or award)
  3. 4 Grant or award EVP, Scientific Strategy & CSO acquired 59,490 shares (grant or award)
  4. 4 Open-market sale Director sold 21,301 shares at $21.00 ($447,321)
  5. 4 Open-market sale EVP and General Counsel sold 18,000 shares at $20.00 ($360,000)
  6. 4 Open-market sale EVP, Commercial sold 31,238 shares at $19.53 ($610,078)
  7. 4 Open-market sale Director sold 84,515 shares at $19.56 ($1,653,113)
  8. 4 Open-market sale Director sold 20,000 shares at $19.49 ($389,800)
  9. 4 Shares withheld for taxes EVP, Scientific Strategy & CSO gave up 20,177 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP and General Counsel gave up 12,226 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 65,147 shares (to pay taxes)
  12. 4 Shares withheld for taxes EVP and CFO gave up 18,327 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, Commercial gave up 15,527 shares (to pay taxes)
  14. 5 Insider Annual Insider Trading Report
  15. 4 Open-market sale EVP, Commercial sold 60,000 shares at $17.91 ($1,074,600)
  16. 4 Shares withheld for taxes EVP, Prod Dev & Med Aff &CMO gave up 7,613 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Shares withheld for taxes President and CEO gave up 12,236 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP, Commercial gave up 1,556 shares (to pay taxes)
  20. 4 Open-market sale EVP, Scientific Strategy & CSO sold 47,500 shares at $17.44 ($828,400)

Page 15 of 73 · 1,458 filings